Cargando…
Gut Microbiota and Clinical Disease: Obesity and Nonalcoholic Fatty Liver Disease
The prevalence of obesity is increasing worldwide. Obesity can cause hyperlipidemia, hypertension, cardiovascular diseases, metabolic syndrome and non-alcoholic fatty liver disease (NAFLD). Many environmental or genetic factors have been suggested to contribute to the development of obesity, but the...
Autores principales: | Park, Ji Sook, Seo, Ji Hyun, Youn, Hee-Shang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3746040/ https://www.ncbi.nlm.nih.gov/pubmed/24010102 http://dx.doi.org/10.5223/pghn.2013.16.1.22 |
Ejemplares similares
-
Food and Gut Microbiota-Derived Metabolites in Nonalcoholic Fatty Liver Disease
por: Jeong, Min Kyo, et al.
Publicado: (2022) -
Characterization of gut dominant microbiota in obese patients with nonalcoholic fatty liver disease
por: Jin, Li-ting, et al.
Publicado: (2023) -
Implication of Gut Microbiota in Nonalcoholic Fatty Liver Disease
por: Boursier, Jerome, et al.
Publicado: (2015) -
Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanism and Application of Metabolomics
por: He, Xuyun, et al.
Publicado: (2016) -
The Roles of the Gut Microbiota and Toll-like Receptors in Obesity and Nonalcoholic Fatty Liver Disease
por: Miura, Kouichi, et al.
Publicado: (2017)